Trial intelligence / Profile preview

SPARC1401 in Acute Low Back Pain

NCT02887534Phase 2Withdrawn

Sponsor
Sun Pharma
Start
Nov 2016
Primary completion
Dec 2017
Modality
Small Molecules
01

Overview

A Phase 2 trial of SPARC1401 in acute low back pain, sponsored by Sun Pharma. Planned start Nov 2016; status: withdrawn.

02

Drugs

SPARC1401
03

Conditions

acute low back pain

Beyond the preview

Go deeper on NCT02887534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02887534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call